Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Cividini, Camilla
Basaia, Silvia
Spinelli, Edoardo G.
Castelnovo, Veronica
Leocadi, Michela
Canu, Elisa
Agosta, Federica
Article History
Received: 25 October 2022
Revised: 5 June 2023
Accepted: 22 June 2023
First Online: 6 July 2023
Competing interests
: The authors declare no conflict of interest in relation to the submitted work. Potential conflicts of interest outside the reported study are: MF is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences</i>, and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla. CC, SB, EGS, VC, ML, and EC have nothing to disclose. FA is Associate Editor of <i>NeuroImage: Clinical</i>, has received speaker honoraria from Biogen Idec, Roche, Zambon and italfarmaco, and receives or has received research supports from the Italian Ministry of Health, Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council and Foundation Research on Alzheimer Disease.